Affymetrix Inc (AFFX)

14.01
0.02 0.14
NASDAQ : Technology
Prev Close 13.99
Open 14.03
Day Low/High 14.00 / 14.05
52 Wk Low/High 8.28 / 16.15
Volume 5.03M
Avg Volume 3.49M
Exchange NASDAQ
Shares Outstanding 80.54M
Market Cap 1.13B
EPS 0.13
P/E Ratio 107.61
Div & Yield N.A. (N.A)
Affymetrix Announces Research Collaboration With Massachusetts General Hospital To Validate And Develop New Oncology Biomarker Tests

Affymetrix Announces Research Collaboration With Massachusetts General Hospital To Validate And Develop New Oncology Biomarker Tests

Affymetrix, Inc. (NASDAQ:AFFX) today announced a research collaboration and licensing agreement with Massachusetts General Hospital (MGH) to co-develop new cancer biomarker tests using the Affymetrix’...

Affymetrix And Leica Microsystems Announce Worldwide Collaboration On Automated, Single-Copy, RNA In Situ Hybridization (ISH) Tissue Assay For Research Use

Affymetrix And Leica Microsystems Announce Worldwide Collaboration On Automated, Single-Copy, RNA In Situ Hybridization (ISH) Tissue Assay For Research Use

Affymetrix, Inc. (NASDAQ:AFFX) and Leica Microsystems are pleased to announce a world-wide collaboration that automates Affymetrix’ QuantiGene® ViewRNA ISH Tissue Assay on the Leica BOND RX...

Affymetrix And ScreenCell Announce Worldwide Distribution Agreement For Circulating Tumor Cell (CTC) Technology

Affymetrix And ScreenCell Announce Worldwide Distribution Agreement For Circulating Tumor Cell (CTC) Technology

Affymetrix, Inc. (NASDAQ: AFFX) and ScreenCell, a privately-held company, today announced the signing of a worldwide distribution agreement for ScreenCell’s isolation devices and dilution buffers,*...

Affymetrix To Webcast Annual Meeting Of Shareholders

Affymetrix To Webcast Annual Meeting Of Shareholders

Affymetrix, Inc. (Nasdaq:AFFX) today invited investors and interested parties to hear a live webcast of its Annual Shareholder Meeting at 8:00am PT on Friday, May 11 th, 2012.

Affymetrix's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Affymetrix's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Affymetrix's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Affymetrix And EBioscience Amend Definitive Merger Agreement

Affymetrix And EBioscience Amend Definitive Merger Agreement

Affymetrix, Inc., (NASDAQ:AFFX) and eBioscience, Inc.

Affymetrix Reports First Quarter 2012 Results

Affymetrix Reports First Quarter 2012 Results

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the first quarter of 2012.

Affymetrix To Host Conference Call On May 3, 2012 To Announce First Quarter 2012 Operating Results

Affymetrix To Host Conference Call On May 3, 2012 To Announce First Quarter 2012 Operating Results

Affymetrix, Inc. (NASDAQ: AFFX) today announced that its first quarter 2012 operating results will be reported after market close on Thursday May 3, 2012.

Affymetrix Announces A Global Distribution Agreement With Almac To Distribute Its Proprietary Xcel™ Array For Translational Research Applications

Affymetrix Announces A Global Distribution Agreement With Almac To Distribute Its Proprietary Xcel™ Array For Translational Research Applications

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it has signed a global distribution agreement with Almac Group Ltd.

Affymetrix Axiom(R) Exome Genotyping Arrays (Photo: Business Wire)

Affymetrix Axiom(R) Exome Genotyping Arrays (Photo: Business Wire)

Affymetrix, Inc. (NASDAQ:AFFX) today announced the release and immediate shipment of its Axiom Exome Genotyping Arrays, which provide the highest coverage of novel, putatively functional coding variants available.

China Clears Its First Microarray Platform For In Vitro Diagnostics To Accelerate Personalized Medicine

China Clears Its First Microarray Platform For In Vitro Diagnostics To Accelerate Personalized Medicine

Affymetrix, Inc. (NASDAQ:AFFX) today announced that its GeneChip ® System 3000Dx v.

Affymetrix's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Affymetrix's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Affymetrix's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Affymetrix Reports Fourth Quarter And Fiscal Year 2011 Results

Affymetrix Reports Fourth Quarter And Fiscal Year 2011 Results

Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the fourth quarter and fiscal year ended December 31, 2011.

5 Stocks Set to Soar on Bullish Earnings

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

Affymetrix To Host Conference Call On February 8, 2012 To Announce Fourth Quarter And FY11 Operating Results

Affymetrix To Host Conference Call On February 8, 2012 To Announce Fourth Quarter And FY11 Operating Results

Affymetrix, Inc. (NASDAQ:AFFX) today announced its fourth quarter and fiscal year 2011 operating results will be reported on Wednesday, February 8, 2012, after market close.

Affymetrix And BGI Enter Strategic Collaboration To Co-Develop And Commercialize Genomic Microarrays For The Agricultural Community

Affymetrix And BGI Enter Strategic Collaboration To Co-Develop And Commercialize Genomic Microarrays For The Agricultural Community

Affymetrix, Inc. (NASDAQ:AFFX), announced today that it has signed a Memorandum of Understanding (MOU) with BGI, the world’s largest genomics organization, to enter into a strategic co-development and co-marketing ...

Affymetrix Stock Hits New 52-Week Low (AFFX)

Affymetrix Stock Hits New 52-Week Low (AFFX)

Affymetrix (Nasdaq:AFFX) hit a new 52-week low Monday as it is currently trading at $3.74, below its previous 52-week low of $3.75 with 586,455 shares traded as of 2:54 p.m. ET. Average volume has been 1.2 million shares over the past 30 days.

Affymetrix Stock Hits New 52-Week Low (AFFX)

Affymetrix Stock Hits New 52-Week Low (AFFX)

Affymetrix (Nasdaq:AFFX) hit a new 52-week low Friday as it is currently trading at $4.02, below its previous 52-week low of $4.04 with 17,879 shares traded as of 9:40 a.m. ET. Average volume has been 1.2 million shares over the past 30 days.

Affymetrix To Acquire EBioscience

Affymetrix To Acquire EBioscience

Affymetrix, Inc., (NASDAQ:AFFX) today announced that it has signed a definitive agreement to acquire eBioscience, Inc.

Affymetrix Completes Strategic Licensing Agreement With Genisphere For Proprietary MicroRNA Reagents

Affymetrix Completes Strategic Licensing Agreement With Genisphere For Proprietary MicroRNA Reagents

Affymetrix®, Inc. (NASDAQ:AFFX) announced today at the Association of Molecular Pathology (AMP) conference that they have entered into an exclusive agreement with Genisphere®, LLC, to offer the...

Affymetrix Enables Analysis Of Challenging Sample Types Through Exclusive Agreement With Genisphere

Affymetrix Enables Analysis Of Challenging Sample Types Through Exclusive Agreement With Genisphere

Affymetrix®, Inc. (NASDAQ:AFFX) announced today that it has entered into an exclusive, worldwide licensing agreement with Genisphere®, LLC, for RNA amplification and labeling technology to address ...

Affymetrix's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Affymetrix's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Affymetrix's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Affymetrix Reports Third Quarter Results

Affymetrix Reports Third Quarter Results

Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the third quarter of 2011.

Affymetrix Announces Cancer-Profiling Collaboration

Affymetrix Announces Cancer-Profiling Collaboration

Affymetrix, Inc. (NASDAQ:AFFX) today announced that the company has entered into an agreement with the Broad Institute to chart the genomic changes involved in more than 20 types of cancer as part of the Broad’s ...

Affymetrix Axiom Array Plates (Photo: Business Wire)

Affymetrix Axiom Array Plates (Photo: Business Wire)

Affymetrix®, Inc. (NASDAQ:AFFX) today announced at the ICHG/ASHG annual conference in Montreal, the worldwide launch of the Axiom® Genome-Wide Pan-African Array, the first commercial product to maximize...

Affymetrix To Host Conference Call On November 2, 2011 To Announce Third Quarter Operating Results

Affymetrix To Host Conference Call On November 2, 2011 To Announce Third Quarter Operating Results

Affymetrix, Inc. (NASDAQ:AFFX) today announced its third quarter 2011 operating results will be reported on Wednesday, November 2, 2011, after market close.

ServiceSource, Illumina: After-Hours Trading

ServiceSource, Illumina: After-Hours Trading

Shares of ServiceSource jump in late trades after the company issues a strong third-quarter forecast.

Affymetrix Gene 1.1 ST Array Strips (Photo: Business Wire)

Affymetrix Gene 1.1 ST Array Strips (Photo: Business Wire)

Affymetrix®, Inc. (NASDAQ: AFFX) today announced commercialization of 18 new array designs for whole-transcriptome analysis of model and applied research organisms that will allow scientists to obtain a more complete ...

Not So Illuminated

It will likely be difficult for Illumina to realize its revenue-growth plans -- and the uncertainties surrounding its business should keep a lid on the stock price.

Affymetrix Announces Federal Court Affirms Dismissal Of Illumina Patent Infringement Lawsuits

Affymetrix Announces Federal Court Affirms Dismissal Of Illumina Patent Infringement Lawsuits

Affymetrix, Inc. (NASDAQ:AFFX) (the “Company”) today announced that the U.